Skip to content

Managing Migraine through Ayurveda with the intake of Tablet Laghu Sutashekhar Rasa and Brihat Dashmoola Taila as Nasal drops.

Efficacy of Laghu Sutashekhara Rasa with and without Brihata Dashmoola Taila Nasya in the management of Migraine - An open labelled randomized comparative clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051278
Enrollment
30
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group 18 to 60 years, presenting with signs and symptoms of Migraine will be included in the study. 2. Chronicity of the disease up to 10 years. 3. The diagnosis of the disease shall be done on the basis of clinical manifestations like a recurrent attack of headache, mostly unilateral in site, variable in intensity, frequency, and duration with or without nausea, vomiting, aura, and GI tract symptoms.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and above 60 years. 2. Chronicity of the disease for more than 10 years will be excluded. 3. Patients suffering from any chronic debilitating disease, with other neurological pathology, E.N.T., pathology, and cases that require surgical intervention will be excluded from the study. 4. Patients suffering from sinusitis, hypertension, secondary headache caused by meningitis, tumor, encephalitis, cervical spondylitis, and refractive errors will be excluded from the study. 5. Patients using any other systemic drugs which may alter the results of the study.

Design outcomes

Primary

MeasureTime frame
Decrease in episodes of chief complaints of Migraine.Timepoint: 45 days

Secondary

MeasureTime frame
Improvement in quality of life.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr D B Vaghela
drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026